semaglutide adolescent Oral Shows Promise in Adolescents with Type 2 Diabetes Obesity rates lead to rise
Description
The use of gut-hormone receptors agonists as new therapeutic options for obesity and some of its related comorbidities, such as type 2 diabetes, has resulted in an unprecedented efficacy in the medical management of people living with obesity (PLWO)
Written by Dr
Ascend Custom GLP-1 is a once-weekly injectable medication primarily used for the treatment of type 2 diabetes and obesity
H., & Choi, M.-S
A small percentage of BAs are deconjugated by gut bacteria, forming secondary BAs, which are reabsorbed or excreted in feces
Clinical Take-Home Messages "Maximize before you switch" may be a reasonable strategy
